Liver enzyme abnormalities after poly ICLC infusions.
W A
WA
Hess
C T
CT
Bever
D E
DE
McFarlin
D000328:Adult; D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use* / Q000031:analogs & derivatives; D006801:Humans; D007372:Interferons / Q000096:biosynthesis; D008099:Liver / Q000201:enzymology*; D008297:Male; D008747:Methylcellulose / Q000031:analogs & derivatives*; D009103:Multiple Sclerosis / Q000188:drug therapy; D011070:Poly I-C / Q000627:therapeutic use*; D011107:Polylysine / Q000627:therapeutic use* / Q000031:analogs & derivatives
D011107:Polylysine; C019531:poly ICLC; D008747:Methylcellulose; D007372:Interferons; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C